Clinical Trial

Repurposing Tilmanocept for Cardiac Sarcoidosis

Name: Repurposing Tilmanocept for Cardiac Sarcoidosis — clinical trial record (NCT07159074)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to see if Tc 99m Tilmanocept SPECT/CT imaging can be used to identify cardiac sarcoidosis.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-08-28; most recent amendment 2026-03-24.

Status change: Not Yet Recruiting → Recruiting 2025-10-24

Trial Details

NCT Number	NCT07159074
Lead Sponsor	Duke University Collaborators: Foundation for Sarcoidosis Research
Conditions	Cardiac Sarcoidosis
Enrollment	15 participants
Start Date	2025-09-17
Primary Completion	2026-12-01 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-27